Gonadotropin-releasing hormone agonist overuse: urologists' response to reimbursement and characteristics associated with persistent overuse

scientific article published on 7 April 2015

Gonadotropin-releasing hormone agonist overuse: urologists' response to reimbursement and characteristics associated with persistent overuse is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/PCAN.2015.10
P932PMC publication ID4430363
P698PubMed publication ID25849354
P5875ResearchGate publication ID274643553

P50authorShellie EllisQ60663757
Stephanie B WheelerQ103811871
P2093author name stringH Liu
G L Jackson
M Weinberger
M E Nielsen
W R Carpenter
P2860cites work2003 American Urological Association Gallup survey: physician practice patterns, cryosurgery/brachytherapy, male infertility, female urology and insurance/professional liabilityQ38478948
NCCN Practice Guidelines for Prostate Cancer.Q39558609
Medicare reimbursement and prescribing hormone therapy for prostate cancerQ42786059
How Medicare's payment cuts for cancer chemotherapy drugs changed patterns of treatmentQ43014207
Reimbursement policy and androgen-deprivation therapy for prostate cancerQ46147188
The watchmanQ47210010
United States life tables, 2000Q72990296
Combination of the preoperative PSA level, biopsy gleason score, percentage of positive biopsies, and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancerQ73591128
Trends in survival after surgery for cholangiocarcinoma: a 30-year population-based SEER database analysisQ81100678
Does reimbursement influence chemotherapy treatment for cancer patients?Q82755224
Identifying specific chemotherapeutic agents in Medicare data: a validation studyQ30413422
Accountable care organization musical chairs: will there be a seat remaining for the small group or solo practice? [corrected].Q30557309
Development of a comorbidity index using physician claims dataQ30623996
Overview of the SEER-Medicare data: content, research applications, and generalizability to the United States elderly populationQ30714715
Use of SEER-Medicare data for measuring cancer surgeryQ30714802
Linking physician characteristics and medicare claims data: issues in data availability, quality, and measurementQ30714854
Studying radiation therapy using SEER-Medicare-linked dataQ33184144
HPRI data tracks. Urology workforce trendsQ34153458
Contemporary role of androgen deprivation therapy for prostate cancerQ34211155
Bias due to missing SEER data in D'Amico risk stratification of prostate cancerQ34231195
National Institutes of Health State-of-the-Science Conference: role of active surveillance in the management of men with localized prostate cancerQ34255849
Reduction in physician reimbursement and use of hormone therapy in prostate cancerQ34406403
Five years after To Err Is Human: what have we learned?Q34419605
Associations between physician characteristics and quality of careQ34475041
Physician visits prior to treatment for clinically localized prostate cancer.Q34610617
Guideline for the management of clinically localized prostate cancer: 2007 update.Q34629234
Projections of the cost of cancer care in the United States: 2010-2020.Q35022830
Physician characteristics and variability of erythropoiesis-stimulating agent use among Medicare patients with cancerQ35187820
Determinants of androgen deprivation therapy use for prostate cancer: role of the urologistQ35754343
Systematic review: the relationship between clinical experience and quality of health careQ36041605
Implementation Science six years on--our evolving scope and common reasons for rejection without reviewQ36236009
Characteristics of urologists predict the use of androgen deprivation therapy for prostate cancerQ36303686
A refined comorbidity measurement algorithm for claims-based studies of breast, prostate, colorectal, and lung cancer patientsQ36832684
Factors influencing the adoption of an innovation: an examination of the uptake of the Canadian Heart Health Kit (HHK).Q36936708
Physicians with the least experience have higher cost profiles than do physicians with the most experienceQ37092385
Hospital racial composition and the treatment of localized prostate cancerQ37139352
How, when, and why do physicians choose careers in academic medicine? A literature reviewQ37721720
Overuse of health care services in the United States: an understudied problemQ37978204
A systematic review on the effectiveness of group versus single-handed practiceQ38126199
P433issue2
P304page(s)173-181
P577publication date2015-04-07
P1433published inProstate Cancer and Prostatic DiseasesQ2108326
P1476titleGonadotropin-releasing hormone agonist overuse: urologists' response to reimbursement and characteristics associated with persistent overuse
P478volume18

Reverse relations

cites work (P2860)
Q37125012Are Small Reimbursement Changes Enough to Change Cancer Care? Reimbursement Variation in Prostate Cancer Treatment.
Q64324086Four Needles in a Haystack: A Systematic Review Assessing Quality of Health Care in Specialty Practice by Practice Type
Q52610761Medication overuse in oncology: current trends and future implications for patients and society.
Q36370093Overuse of Health Care Services in the Management of Cancer: A Systematic Review

Search more.